BIO.WA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 May 2024 @ 11:00):

Stats
Today's Volume	34 135.00
Average Volume	33 941.00
Market Cap	303.96M
EPS	PLN-0.0514 ( 2023-09-30 )
Last Dividend	PLN0 ( N/A )
Next Dividend	PLN0 ( N/A )
P/E	118.00
ATR14	PLN0.00800 (0.23%)

BIOTON S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BIOTON S.A. Financials

Annual	2023
Revenue:	PLN181.64M
Gross Profit:	PLN72.85M (40.11 %)
EPS:	PLN0.0265

FY	2023
Revenue:	PLN181.64M
Gross Profit:	PLN72.85M (40.11 %)
EPS:	PLN0.0265

FY	2022
Revenue:	PLN233.16M
Gross Profit:	PLN95.75M (41.07 %)
EPS:	PLN0.0166

FY	2021
Revenue:	PLN163.03M
Gross Profit:	PLN77.79M (47.71 %)
EPS:	PLN0.0300

Financial Reports:

No articles found.

BIOTON S.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BIOTON S.A.

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.